ConKay Medical Systems Adds Top Cardiologist to Advisory Board, Moves to Larger Headquarters

Medtech Innovator highlights Conkay Medical as a finalist in the AHA Accelerator Program

Conkay Medical is a top 5% selection in the prestigious 2022 MedTech innovotar’s Program

Conkay Medical Systems Recieves $1.8 M in Oversubscribed Seed Funding Round

Top 6 finalist in the 2022 prestigious American Heart Association Business Accelerator Program

Conkay’s Valvular Seed Round

Conkay Medical Secures $1.8 M in Oversubscribed Seed Funding

Top Finalist for the 2023 UCSF Rosenman Innovator

$1.8M to Advance Valvular Regurgitation Treatment Technology

Beating Heart Disease: How ConKay leads the charge against Valvular Regurgitation?